Firdapse Tablet
Product Images NDC 69616-211

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Firdapse (NDC 69616-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Catalyst Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Firdapse 01)

Chemical structure diagram of amifampridine phosphate, showing a six-membered ring with two amino groups attached and a phosphate group indicated.*

FDA Label Image

Principal Display Panel (10 mg Tablet Blister Pack Carton)

The packaging label for Firdapse (amifampridine) Tablets, 10 mg per tablet, oral dosage form. The label indicates a total of 120 tablets provided in 12 child-resistant blister cards of 10 tablets each. Labeler is Catalyst Pharmaceuticals, Inc. The label includes storage instructions, a barcode, and space for GTIN, serial number, expiration date, and lot number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.